| 2.68 -0.07 (-2.55%) | 06-12 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 3.24 |
1-year : | 3.43 |
| Resists | First : | 2.77 |
Second : | 2.94 |
| Pivot price | 2.75 |
|||
| Supports | First : | 2.51 |
Second : | 2.09 |
| MAs | MA(5) : | 2.74 |
MA(20) : | 2.73 |
| MA(100) : | 2.63 |
MA(250) : | 2.52 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 33.5 |
D(3) : | 47.9 |
| RSI | RSI(14): 46.4 |
|||
| 52-week | High : | 3.43 | Low : | 1.84 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ CRON ] has closed above bottom band by 7.1%. Bollinger Bands are 28% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.77 - 2.79 | 2.79 - 2.8 |
| Low: | 2.65 - 2.66 | 2.66 - 2.67 |
| Close: | 2.66 - 2.68 | 2.68 - 2.7 |
Cronos Group Inc. is a company primarily focused on cannabinoids. In the United States, it develops, promotes, and supplies hemp-derived wellness and beauty products under the Lord Jones and Happy Dance brands, reaching consumers through online sales, traditional retail outlets, and partnerships within the hospitality sector. Beyond hemp, the company also engages in the cultivation, production, and commercialization of cannabis and its related extracts for both therapeutic and recreational consumption. Its cannabis offerings encompass dried flower, pre-rolled joints, edibles, concentrates, and various extracts, which are distributed via wholesale channels and directly to clients. The wellness segment operates under the PEACE NATURALS platform, while its adult-use products are marketed through the Spinach brand. Additionally, Cronos exports dried cannabis and cannabis oils to international markets such as Germany, Israel, and Australia. Founded in 2012, the company's headquarters are located in Toronto, Canada.
Thu, 11 Jun 2026
Canada's top cannabis vape brand adds 'liquid diamond' flavors - Stock Titan
Tue, 09 Jun 2026
Cronos Group Inc (NASDAQ:CRON) Passes Minervini Trend Template and High Growth Momentum Screen - ChartMill
Sun, 31 May 2026
Cronos Group Inc (CRON) Stock Was Rising. Can the Rally Continue After Q1 Results? - Yahoo Finance
Mon, 11 May 2026
Cronos Group Reports 2026 First Quarter Results - GlobeNewswire
Mon, 11 May 2026
Cronos Group Inc. (CRON) Reports Record Revenue and Market Growt - GuruFocus
Mon, 11 May 2026
Cronos Group Inc. (CRON) Stock Falls on Q1 2026 Earnings - Quiver Quantitative
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 374 (M) |
| Shares Float | 192 (M) |
| Held by Insiders | 48.4 (%) |
| Held by Institutions | 15.7 (%) |
| Shares Short | 4,020 (K) |
| Shares Short P.Month | 4,560 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.84 |
| Profit Margin | -1.2 % |
| Operating Margin | -1.2 % |
| Return on Assets (ttm) | -0.8 % |
| Return on Equity (ttm) | 0.4 % |
| Qtrly Rev. Growth | 40 % |
| Gross Profit (p.s.) | 0.16 |
| Sales Per Share | 0.42 |
| EBITDA (p.s.) | -0.01 |
| Qtrly Earnings Growth | 126.8 % |
| Operating Cash Flow | 39 (M) |
| Levered Free Cash Flow | -15 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0.94 |
| Price to Sales | 6.27 |
| Price to Cash Flow | 25.76 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|